SEC Comment Letter for United Health Products, (UEEC) — Sep 14, 2022
United Health Products, Inc.
Date: Sept. 14, 2022 · CIK: 0001096938 · Accession: 0000000000-22-010068
AI Filing Summary & Sentiment
File numbers found in text: 333-267310
Letter
United States securities and exchange commission logo September 14, 2022 Brian Thom Chief Executive Officer United Health Products, Inc. 526 Commerce Circle, STE #102 Mesquite, NY 89027 Re:United Health Products, Inc. Registration Statement on Form S-3 Filed September 7, 2022 File No. 333-267310 Dear Mr. Thom: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gavin Grusd, Esq.
Show Raw Text
United States securities and exchange commission logo
September 14, 2022
Brian Thom
Chief Executive Officer
United Health Products, Inc.
526 Commerce Circle, STE #102
Mesquite, NY 89027
Re:United Health Products, Inc.
Registration Statement on Form S-3
Filed September 7, 2022
File No. 333-267310
Dear Mr. Thom:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Gavin Grusd, Esq.